FDA issued a Warning Letter to Hybrid Pharma, LLC on 11/30/2018 as a result of this inspection.
FDA investigators audited the Hybrid Pharma - Deerfield Beach, FL, United States facility and issued 9 inspectional observations (via FDA 483) on 28 Jul 2016.
Add To Cart
- Category: Human Drugs
- Number of Observations: 9
- Inspection end: 28 Jul 2016
- Location: Deerfield Beach, United States
- FEI: 3011319445